Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q15408418> ?p ?o }
Showing triples 1 to 34 of
34
with 100 triples per page.
- Q15408418 subject Q8431776.
- Q15408418 subject Q8462603.
- Q15408418 abstract "Cadazolid is an experimental antibiotic of the oxazolidinone class made by Actelion Pharmaceuticals Ltd. which is effective against Clostridium difficile, a major cause of drug resistant diarrhea in the elderly. Current drug treatments for this infection involve orally delivered antibiotics, principally fidaxomicin, metronidazole and vancomycin; the last two drugs are the principal therapeutic agents in use, but fail in approximately 20 to 45% of the cases. The drug is in Phase III trials. The drug works by inhibiting synthesis of proteins in the bacteria, thus inhibiting the production of toxins and the formation of spores.".
- Q15408418 atcPrefix "none".
- Q15408418 casNumber "1025097-10-2".
- Q15408418 iupacName "1-Cyclopropyl-6-fluoro-7-[4-({2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenoxy}methyl)-4-hydroxypiperidin-1-yl]-4-oxo-1,4-dihydroquinolin-3-carboxylic acid".
- Q15408418 thumbnail Cadazolid.svg?width=300.
- Q15408418 wikiPageWikiLink Q11083.
- Q15408418 wikiPageWikiLink Q12187.
- Q15408418 wikiPageWikiLink Q1539893.
- Q15408418 wikiPageWikiLink Q169569.
- Q15408418 wikiPageWikiLink Q221681.
- Q15408418 wikiPageWikiLink Q310543.
- Q15408418 wikiPageWikiLink Q34.
- Q15408418 wikiPageWikiLink Q343217.
- Q15408418 wikiPageWikiLink Q40878.
- Q15408418 wikiPageWikiLink Q424027.
- Q15408418 wikiPageWikiLink Q425555.
- Q15408418 wikiPageWikiLink Q426549.
- Q15408418 wikiPageWikiLink Q500256.
- Q15408418 wikiPageWikiLink Q5446672.
- Q15408418 wikiPageWikiLink Q8431776.
- Q15408418 wikiPageWikiLink Q8462603.
- Q15408418 atcPrefix "none".
- Q15408418 casNumber "1025097".
- Q15408418 iupacName "1".
- Q15408418 type ChemicalSubstance.
- Q15408418 type Drug.
- Q15408418 type ChemicalObject.
- Q15408418 type Thing.
- Q15408418 type Q8386.
- Q15408418 comment "Cadazolid is an experimental antibiotic of the oxazolidinone class made by Actelion Pharmaceuticals Ltd. which is effective against Clostridium difficile, a major cause of drug resistant diarrhea in the elderly. Current drug treatments for this infection involve orally delivered antibiotics, principally fidaxomicin, metronidazole and vancomycin; the last two drugs are the principal therapeutic agents in use, but fail in approximately 20 to 45% of the cases. The drug is in Phase III trials.".
- Q15408418 label "Cadazolid".
- Q15408418 depiction Cadazolid.svg.